23 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
15 Jun 24
]
On April 10, 2024, the U.S. Department of Justice ("DOJ") issued a press release announcing that it had filed
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
13 Jun 24
for information about joining the class action] On April 10, 2024, the U.S. Department
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
operations (including the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN
REGN
5 Jun 24
for information about joining the class action] On April 10, 2024, the U.S. Department
tpxheu2563xo0giw3evn3dre0ulu 05f
REGN
3 Jun 24
the class action] On April 10, 2024, the U.S. Department of Justice ("DOJ") issued a press release announcing that it had filed a complaint
ki1kryxdd73i 9ihqoov5bw
REGN
31 May 24
the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District
2s2tiqch77s71jivj0tlri1yhgngl3s3g6pes7ddhx1od9ywlnx
REGN
31 May 24
(including the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District
d40x3azgq41gvhr9qkzzaptlcxnmbc
REGN
31 May 24
civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts
3k5d05bq6cr93h499gc
REGN
31 May 24
to the Company and/or its operations (including the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S
2c46mrkwnbr
REGN
30 May 24
]
On April 10, 2024, the U.S. Department of Justice ("DOJ") issued a press release announcing that it had filed
lq3p8170m v0a30g28rchs3ts7jw7gr5mskikjgkvc1594vn8gbszp
REGN
28 May 24
for information about joining the class action] On April 10, 2024, the U.S. Department of Justice
2kp3b4k
REGN
23 May 24
civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts
m012e9wjkhq9bikj9edihi3d8y41f0v3r8wvj
REGN
22 May 24
]
On April 10, 2024, the U.S. Department of Justice
73dywkv mgv530txm
REGN
20 May 24
for information about joining the class action] On April 10, 2024, the U.S. Department of Justice
eryicdmy4l9r8l2i6ovujususu2p38uuoykisyelq2cegi5oomior
REGN
20 May 24
. Severe exacerbations were defined as those requiring hospitalization; requiring more than a day of observation in an emergency department or urgent
0jtjalbbpi5fhm9p5hcz
REGN
20 May 24
a day of observation in an emergency department or urgent care facility; or resulting in death. Key secondary endpoints included change from baseline
fkqfbz5 d4ljg0b1f7y
REGN
16 May 24
]
On April 10, 2024, the U.S. Department of Justice ("DOJ") issued a press release announcing its complaint filed against Regeneron under
zwr85ru4eocu4pziig8gt8pcutexje6g7utyiq78c5sfym9hnkq59rffk
REGN
8 May 24
," said Lawrence R. Lustig, M.D., Chair of Columbia University's Department of Otolaryngology - Head & Neck Surgery and a clinical trial investigator
dvk8pzprp32jz35g3i675c8a4f8u
REGN
2 May 24
. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts), the ultimate outcome of any such proceedings